Free Webinar | Hydration Beyond Hyaluronic: Is Your Product Ready for Osmotic Stress?​ Register Now

The Three Safest API Bets for 2026 Generic Drug Entry

The Three Safest API Bets for 2026 Generic Drug Entry

Seventeen high-revenue small-molecule drugs were examined beyond simple patent expiry timelines. The review incorporated regulatory protections, competitor filings, and supply arrangements, factors that often surface late in the planning cycle and materially alter launch feasibility. Timing proved decisive. Several of them that appeared viable at first narrowed quickly when secondary protections persisted, or competitive activity […]

Largest Patent Buyers in 2025 and What Their Acquisitions Signal

npe buyers

In February 2025, Peninsula Technologies acquired 364 patents from Ofinno, and in April 2025, Dish Wireless was sued. With just 63 days, the acquisition-to-enforcement window of licensing companies has shrunk from years to weeks, and the need to be on the toes with these acquisition activities has never been higher. Peninsula Technology’s purchase was among […]

European generic drug opportunities surge as major medicines lose exclusivity in 2026

EMA approved Drug Expiry list in Europe

As healthcare budgets across Europe remain under pressure, 2026 marks an important turning point. Multiple high-cost medicines are scheduled to lose regulatory exclusivity, enabling future price competition and expanded patient access. Understanding which therapies are affected and when is essential for both policymakers and pharmaceutical manufacturers. The article lists European drug exclusivities expiring in 2026. […]

Fewer Patents & Bigger Risks: What’s Really Happening in 5G-Advanced?

5G Advanced Technology Trends

The evolution of 5G has entered a new phase, one defined not just by faster speeds but by intelligence, adaptability, and cross-domain integration. As 5G-Advanced continues to mature through 2026, it is unlocking capabilities that go far beyond mobile broadband.  Technologies like AI-driven network intelligence, edge computing, non-terrestrial (satellite) networks, and integrated sensing and communication […]

Wi-Fi 7 Signals That Will Decide Who Leads & Who Pays in Licensing in 2026

wifi 7

Key insights: Apple’s iPhone 17 launch quietly confirmed a turning point for Wi-Fi 7. By explicitly calling out Multi-Link Operation (MLO), a core feature of the standard, the launch signaled that Wi-Fi 7 has moved beyond lab validation into real-world implementation. Similar product disclosures, combined with a rising number of certified devices, suggest that Wi-Fi […]

Hidden Risks in Chemical FTO Searches & 6 Practical Strategies for a Successful Product Launch

Hidden Risks in Chemical FTO Searches & 6 Practical Strategies for a Successful Product Launch

In the chemical domain, freedom-to-operate (FTO) risk extends far beyond what is immediately visible from a product’s composition or a process flow diagram. Unlike mechanical or electronic inventions, where infringement analysis is often confined to directly claimed structural or functional features, chemical products and processes operate within a highly interconnected ecosystem. At the same time, […]

Building Your 2026 Cellular IoT Licensing Strategy: What the Data Now Reveals

2026 Cellular IoT Licensing Strategy

The licensing framework for Cellular IoT technologies, including NB-IoT, LTE-M, RedCap, and V2X, is quickly becoming unreliable. This is happening because the standardization process itself is evolving rapidly, with each IoT technology entering the market at a different pace and with varying levels of patent involvement. Multiple factors drive the shift in this Cellular IoT […]

Why Traditional Vendor Reports Fall Short in Patent Licensing Negotiations & How to Fix it

licensing negotiations

Licensing teams rarely struggle because the technical work is incomplete. They struggle because the work arrives in pieces. SEP analysis is performed separately. Prior art studies follow a different methodology. Prosecution history reviews sit in another report. Global families appear in yet another spreadsheet.  The problem arises in how these inputs reach the licensing team, […]

Paying $7K a Patent with No ROI? A University Patent Monetization Strategy That Works

University Patent Monetization Strategy

Across the U.S., academic tech transfer is under strain. In 2023, U.S. institutions reported a 33% year-over-year decline in patent licenses. Meanwhile, unused patents keep costing money. Utility patents require three maintenance payments at 3.5/7.5/11.5 years. After the 2025 fee changes, large-entity fees total $14,470 ($2,150 + $4,040 + $8,280). Small-entity nonprofits (which include many […]

6G Enabling Technologies: What Patent Trends Reveal About the Future of Wireless

6G Enabling Technologies

With the IoT devices projected to surpass 24 billion by 2025, the importance of enhanced connectivity has never been more evident. This is where 6G emerges as the zenith. With speeds 100 times faster than 5G and significantly reduced latency, 6G offers significant improvements. Its expanded data capacity and heightened connection density are critical for […]

Strava vs. Garmin, Round Two. The API Dispute is Over but the Patent War Begins

strava vs garmin

“I’d be gutted if Garmin data stopped syncing with Strava,” said Sue Kay, a professional triathlete and a fitness coach. “Garmin gives me the data, but Strava gives me the people.” That fear, shared by millions of athletes, fueled weeks of speculation over whether Garmin’s devices would stop syncing with Strava’s platform on November 1, […]

Video Codec Landscape of 3,916 Patents Reveals the Leaders of Beyond VVC (H.267)

video codec

As the world transitions into the metaverse, 8K streaming, and autonomous systems, the demand for a codec more powerful than H.266/VVC is no longer a distant vision. It’s an immediate necessity. The upcoming standard, Beyond VVC (H.267), is being developed by the Joint Video Experts Team (JVET) and marks a significant change in video compression, […]

Explore the FDA’s 2025 Drug Approvals: What Got Approved, When, and for What

FDA DRUG APPROVALS 2025

In 2025, the FDA has approved 28 new therapies, each signaling how the next decade of pharma innovation and IP strategy will unfold. From oncology and rare diseases to quality-of-life treatments, these approvals mark a shift from chasing blockbusters to building precision-driven, defensible markets. Key Therapeutic Forces Reshaping the 2025 Pipeline Oncology: Cancer remains the […]

The Rise of New Entrants in 6G Standardization

6G standardization

As 6G standardization takes shape, the landscape is already showing signs of fragmentation. 6G Core: Telecom vs. Non-Telecom Who is Leading the Future Standards? 3GPP Contribution Split: The convergence of telecom incumbents and non-telecom innovators. Click or hover on a segment for details. 3GPP Contributors Participation 57% 43% Telecom Incumbents Established leaders focusing on core […]

How Mid-Sized SEP Portfolios Like Panasonic’s Are Leading in 5G Licensing

How Mid Sized SEP Portfolios Like Panasonic’s Are Leading in 5G Licensing (1)

From 2G through 4G, SEP declaration counts became the industry’s shorthand for power. Negotiation dynamics favored raw numbers, with counterparties conceding that more declared families meant broader coverage. Large licensors with huge SEP Portfolios reinforced the equation by filing across dozens of jurisdictions, turning global coverage into bargaining power. Pools too often rewarded contribution counts, […]

Inside Disney’s Patent Strategy: Filings, Litigation Trends, and Licensing Power

disneyPatents

For over a century, Disney has captivated audiences worldwide, blending storytelling magic with technological marvel. Behind the enchanting characters and immersive experiences lies a meticulously managed intellectual property portfolio, a testament to Disney’s unwavering commitment to innovation. As the entertainment landscape rapidly evolves, Disney’s strategic IP management, encompassing a robust patenting program and agile litigation […]